Statistics for Actinium Pharmaceuticals (id:161 ATNM)
Valuation metrics
Market cap
43.36M
Enterprise value
-32,783,280.00
Trailing P/E (ttm)
-0.80
Forward P/E
-2.01
PEG ratio
-2.01
Price/Sales (ttm)
535.34
Price/Book (mrq)
1.06
Enterprise Value/Revenue
-404.73
Enterprise Value/EBITDA
0.70
Overview
Shares outstanding
31.20M
Float
31.00M
Shares short
1.45M
% Held by insiders
0.02%
% Held by institutions
0.30%
Average volume (10 days)
316.74K
Average volume (90 days)
Price summary
52-Week low
1.33
52-Week high
10.24
52-Week change
-203.40%
Beta
0.15
50-Day moving average
1.78
200-Day moving average
5.52
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
August 11th, 2020
Ex-dividend date
Last split factor
2:1
Last split date
August 11th, 2020
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
-57,665.44%
Operational effectiveness
Return on assets
-30.91%
Return on equity
-87.96%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-46,485,000.00
Net income to common (ttm)
-42,623,000.00
Diluted EPS (ttm)
-1.39
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
86.04M
Total cash per share (mrq)
2.76
Total debt (mrq)
1.85M
Total Debt/Equity (mrq)
4.22
Current ratio (mrq)
895.00%
Book value per share (mrq)
1.32
Cash flow
Cash flow statement
-33,961,000.00
Levered free cash flow (LFCF)
-20,060,124.00